JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M109652200 on November 15, 2001

J. Biol. Chem., Vol. 277, Issue 4, 2869-2875, January 25, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/4/2869    most recent
M109652200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaulin-Bastard, F.
Right arrow Articles by Borg, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaulin-Bastard, F.
Right arrow Articles by Borg, J.-P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Interaction between Erbin and a Catenin-related Protein in Epithelial Cells*

Fanny Jaulin-Bastardab, Jean-Pierre Arsantoc, André Le Bivicc, Christel Navarroade, Frédéric Vélyf, Hiroko Saitoag, Sylvie Marchettoa, Mechthild Hatzfeldhi, Marie-Josée Santonia, Daniel Birnbauma, and Jean-Paul Borgadj

From the a U119 INSERM, Molecular Oncology, d Institut Paoli-Calmettes, Molecular Pharmacology, 27 boulevard Leï Roure 13009 Marseille, France, c IBDM, LGPD Faculté des Sciences de Luminy, case 907, 13288 Marseille cedex 09, France, f Centre d'Immunologie de Marseille-Luminy, CNRS-INSERM-Université de la Méditerranée, Parc Scientifique de Luminy, case 906, 13288 Marseille cedex 09, France, and the h Molecular Biology Group, University of Halle, Magdeburger Strasse 18, 06097 Halle, Germany

Received for publication, October 5, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Integrity of epithelial tissues relies on the proper apical-basolateral polarity of epithelial cells. Members of the LAP (LRR and PDZ) protein family such as LET-413 and Scribble are involved in maintaining epithelial cell polarity in Caenorhabditis elegans and Drosophila melanogaster, respectively. We previously described Erbin as a mammalian LET-413 homologue interacting with ERBB2/HER2, an epidermal growth factor receptor family member. Erbin and ERBB2/HER2 are located in the basolateral membranes of epithelial cells. We show here that Erbin interacts with p0071 (also called plakophilin-4), an armadillo repeat protein linked to the cytoskeleton. Erbin binds to p0071 in vitro and in vivo in a PDZ domain-dependent manner, and both proteins colocalized in desmosomes of epithelial cells. Using a dominant negative approach, we found that integrity of epithelial cell monolayer is impaired when interaction between Erbin and p0071 is disrupted. We propose that Erbin is connected by p0071 to cytoskeletal networks in an interaction crucial for epithelial homeostasis.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Integrity of epithelial tissues relies on protein networks involved in targeting of proteins to apical or basolateral membranes and specifying the three-dimensional structure of the cell. Organized epithelial cells have an apical membrane in contact with fluids, intercellular lateral membranes, and a basal membrane connected to extracellular matrices. Apical and basolateral compartments are separated by tight and adherens junctions and contain different sets of proteins and lipids (1-3). These highly organized structures regulate exchanges between extra- and intracellular compartments in normal situations and may be affected in carcinoma and autoimmune diseases.

Asymmetric distributed multiprotein complexes in polarized epithelial cells contain cell adhesion molecules, signaling and structural proteins whose organization relies on protein-protein interactions. They are organized by protein modules that are found in one or more copies in proteins and interact with specific peptides of their binding partner (4). Among the protein modules, PDZ (PSD-95/DLG/ZO-1) domains bind to short peptides and are involved in receptor signaling and targeting. They are conserved from bacteria to mammals (5). PDZ domain proteins are scaffold proteins important for different developmental processes as evidenced by Shroom and Psd-95 knock-outs in mice (6, 7). Recent studies in nonvertebrates have evidenced the role of PDZ protein complexes as crucial for tissue morphogenesis and proper development. Vulval development in Caenorhabditis elegans relies on the LIN-2-LIN-7-LIN-10 complex, whereas PAR-6 and PAR-3 proteins form a complex important for cell polarity in worms and flies. These protein complexes are conserved in mammals and are connected to signaling pathways driven by protein kinases (8-12). Multiple copies of PDZ domains in the same protein help scaffold an array of receptors, enzymes, and adaptors, thus creating a functional unit. This is well documented in the case of INAD, a five-PDZ domain protein, gathering a protein kinase C, calmodulin, phospholipase C, rhodopsin, and light-sensitive Ca2+ channel in a stable transducisome machinery crucial for signaling and stability of photoreceptors (13, 14). Complexity is increased by the possibility for a PDZ domain to bind peptide sequences found in different proteins and conversely for a protein to bind several PDZ domains. For example, PSD-95 binds to glutamate, Shaker K+ channels, and tyrosine kinase receptors as well as to neuroligins at the postsynapse of neurons (15-18).

The LAP family is a novel PDZ domain protein family comprising LET-413 in C. elegans; Scribble in Drosophila melanogaster; and Erbin, Densin-180, hScribble, and Lano in mammals (19). LAP proteins are membrane-bound adaptor proteins and contain 16 amino-terminal leucine-rich repeats and one (LET-413, Densin-180, Erbin), four (Scribble), or no (Lano) PDZ domains. Genetic analyses have thoroughly demonstrated the importance of LAP proteins in worm and fly development and their role in cell polarity and epithelial morphogenesis. Loss of function of let-413 (homologue of Erbin and Densin-180) and scribble (orthologue of hScribble) is embryonic lethal and results in disorganization of the cytoskeleton and disruption of epithelial integrity with mislocalization of apical determinants (20, 21). Despite a genetic interaction existing between scribble and disc large or lethal giant larvae, two other tumor suppressor genes, it is unclear whether the corresponding proteins belong to a common protein complex (22). A similar situation exists in C. elegans (23, 24). Taken together, no protein networks associated to nonvertebrate LAP proteins have yet been identified.

In mammals, the search for LAP interactors has been more successful. Densin-180 is a neuron-specific protein linked to calmodulin kinase II and alpha -actinin (25, 26). hScribble is targeted for degradation by an ubiquitin-ligase activity associated to E6 oncoprotein (27). Lano is associated to human Discs Large (hDLG), a potential tumor suppressor (28). We have characterized the interaction between ERBB2, a mammalian epidermal growth factor receptor family member, and Erbin, which is reminiscent of LET-23/LIN-2-LIN-7-LIN-10 complex interaction. In both cases, PDZ domain interactions are important for receptor localization or retention in epithelial cells (29, 30). The Erbin-ERBB2 interaction takes place at the basolateral side of epithelial cells. The Erbin PDZ domain interacts with ERBB2 and controls its basolateral localization in epithelial cells (29-31). Recently, it was demonstrated that Erbin directly binds to BPAG1 (bullous pemphigoid antigen-1), a component of hemidesmosomes, electron dense structures in contact with the basal membrane associated with the cytoskeleton (32). BPAG1 belongs to the plakin family and is involved in cytoskeletal organization (33). The integrin beta 4 subunit, a cell adhesion molecule involved in hemidesmosome assembly, also associates with Erbin through a protein interaction domain lying amino-terminal to the Erbin PDZ domain (32). It is unknown whether Erbin is present in hemidesmosomes. Although the functional relevance of these novel interactions remains to be appreciated, these data suggest that Erbin is linked to cytoskeleton-associated protein complexes in hemidesmosomes and participates to cell adhesion processes.

In this report, using the two-hybrid system in yeast, we identified p0071 (also called plakophilin-4), a member of the armadillo repeat family, as a new interactor for Erbin. Proteins of the p120-catenin family, including p0071, link cadherin adhesion molecules to the cytoskeleton (34, 35). Interaction is mediated by the p0071 carboxyl-terminal sequence and the Erbin PDZ domain. Erbin and p0071 specifically interact in cultured epithelial cells and tissues. By surface plasmon resonance (SPR)1 analysis, we measured a better affinity between p0071 and Erbin than between ERBB2 and Erbin. Erbin is found at the lateral membrane of epithelial cells and colocalizes with p0071 in desmosomes. Disruption of the p0071-Erbin interaction by a dominant negative approach provoked alteration of cell morphology, suggesting that connection of Erbin to cytoskeletal networks is important for epithelial integrity.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Two-hybrid Procedure-- To prepare the baits used in this paper, proteins or peptides were fused to the LexA-BD subunit using the pBTM116 vector, which carries Trp1. For library screening, an oligo(dT)-primed human cDNA breast library cloned in pACT2 vector (CLONTECH), which carries Leu2 as a selection marker, was screened by using the LexA-Erbin as a bait and the yeast strain L40 following the lithium-acetate protocol. Approximately 106 Trp+Leu+ transformants were selected on plates with supplemented minimum medium that lacked tryptophan, leucine, and histidine in the primary screening and contained 10 mM 3-aminotriazole and then tested for the beta -galactosidase activity by the filter method in the secondary screening. After rescue, the DNA of selected clones was retransformed in L40 yeast containing LexA-Erbin or LexA fused to control proteins. Specific clones were positive for growth in histidine-deficient medium and beta -galactosidase activity.

Protein Procedures-- Cells were washed twice with cold PBS and lysed in lysis buffer (50 mM HEPES, pH 7.5, 10% glycerol, 150 mM NaCl, 1% Triton X-100, 1.5 mM MgCl2, 1 mM EGTA) supplemented with 1 mM phenylmethylsulfonyl fluoride, 10 µg·ml-1 aprotinin, and 10 µg·ml-1 leupeptin. After centrifugation at 16,000 × g for 20 min, lysate protein content was normalized using the Bio-Rad protein assay kit. For immunoprecipitation, lysates were incubated with antibodies overnight at 4 °C. Protein A-agarose was added, and immune complexes bound to beads were recovered after 1 h, washed three times with HNTG buffer (50 mM HEPES, pH 7.5, 10% glycerol, 150 mM NaCl, 0.1% Triton X-100), boiled in 1× sample buffer, and separated by SDS-PAGE. Transfer and immunoblotting on nitrocellulose using a horseradish peroxidase-anti-rabbit or horseradish peroxidase-anti-mouse antibody/chemiluminescence method were performed as described (36).

Cell Culture-- COS-1, human embryonic kidney (HEK) 293, HeLa, and Madin-Darby canine kidney cells were grown in Dulbecco's modified Eagle's medium containing 100 units·ml-1 penicillin and 100 µg·ml-1 streptomycin sulfate, supplemented with 10% fetal calf serum. Caco-2 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 20% fetal calf serum and 1% nonessential amino acids. All cell transfections were made using Fugene 6 reagent according to manufacturer's recommendations (Roche Molecular Biochemicals).

DNA Constructs-- The human Erbin cDNA was used as a template to create different constructs allowing expression of GST, Myc-tagged, LexA-BD, and GAL4 activation domain fusion proteins (29). The RK5-Myc (36) and GFP-C1 (CLONTECH) vectors were used to express proteins fused to the amino-terminal Myc or GFP epitopes. The pGEX-Tag vector was used to produce all GST fusion proteins. Site-directed mutagenesis was performed using the QuikChange kit (Stratagene). All constructs were sequenced by Genome Express, SA (Grenoble, France).

p0071 headless (aa 509-1193), arm repeats (aa 509-989), and tail (aa 990-1193) domains were cloned by RT-PCR from HeLa cell RNA. PCR products were ligated into the PCR2.1TOPO vector (Invitrogen) and fully sequenced. Constructs were then subcloned into the pCDNA4TOmycHis vector (Invitrogen) or pEGFP vector (CLONTECH) for eucaryotic expression or into pGAD424 for two-hybrid analyses.

Antibodies-- Monoclonal anti-Myc 9E10 and polyclonal anti-GFP antibodies are from Oncogene Research Products and CLONTECH, respectively. Goat anti-rabbit and anti-mouse IgG coupled to horseradish peroxidase were purchased from Jackson Laboratories and Dako, respectively. Anti-Erbin polyclonal antibody has been previously described (29). Monoclonal anti-Erbin antibodies were produced by injecting a soluble GST-Erbin-(914-1371) fusion protein to BALB/C mice. Spleen cells of immunized mice were fused to the nonsecreting myeloma X63-Ag8.653 as previously described (37). Culture supernatants were tested by immunoprecipitation on Erbin-containing lysates. Positive clones were cloned twice by limiting dilution.

Monoclonal anti-p0071 antibodies were obtained by immunization of mice with the purified recombinant tail domain expressed in pRSET and E. coli BL21DE3 cells. Clones 5A4-8-3 and 6D1-10 will be described in detail elsewhere.2

Immunolocalization and Cell Surface Labeling-- For immunostaining procedures, MCF-7 cells and Caco-2 cells grown on coverslips for 20 days after confluence were double labeled as described before with an affinity-purified rabbit polyclonal antibody against Erbin (diluted 1:100) (29) and a mouse monoclonal antibody against p0071 (5A4). Images were obtained using a confocal microscope (Zeiss LSM2). Frozen sections (0.5-1.0 µm) of human colon were treated as described (29).

Immunoelectron Microscopy-- Immediately after removal, biopsies of human colon (kindly provided by Dr. Monges, Institut Paoli-Calmettes, Marseille) were fixed at room temperature in 8% paraformaldehyde in PBS+. Tissues were then infiltrated with 2.3 M sucrose in PBS and frozen in liquid nitrogen. Ultrathin cryosections were prepared using a cryo-ultramicrotome and collected on Formvar-coated grids. Sections were successively treated for 30 min with PBS, for 20 min with 0.5 M NH4Cl in PBS, and for 30 min with PBS supplemented with 10% goat serum. They were then incubated overnight at 4 °C with anti-Erbin and anti-p0071 (5A4) antibodies diluted 1:20 or 1:5 in 5% goat serum in PBS, respectively. The grids were rinsed in PBS, and primary antibodies were revealed by incubation for 1 h with colloidal gold 6- or 15-nm conjugated goat anti-rabbit or anti-mouse IgG, respectively, diluted 1:25 in 5% goat serum in PBS. After extensive washing with double-distilled water, sections were rapidly fixed with 2% glutaraldehyde, stained for 6 min with 2% uranyl acetate, rinsed, and treated with 0.3% uranyl acetate and 1.8% methylcellulose in double-distilled water on ice. Sections were air-dried and examined under a Zeiss electron microscope.

Surface Plasmon Resonance Analysis-- Biotinylated (Biotin) peptides were synthesized by Neosystem, SA. Peptide sequences were as follows: Biotin-PTAENPEYLGLDVPV (ERBB2), Biotin-TVLPPPPYRHRNTVV (ERBB4), and Biotin-SYRAEQYPGSPDSWV (p0071).

SPR studies were performed using an upgraded BIAcore apparatus (BIAcore AB, Uppsala, Sweden) and streptavidin-coupled SA sensor chips (BIAcore). In all experiments, HBS (10 mM HEPES (pH 7.4), 150 mM NaCl, 3.4 mM EDTA, and 0.005% Surfactant P20) is used as running buffer. Biotinylated peptides were immobilized at the indicated levels over streptavidin-coupled surfaces. Injection of GST fusion proteins were performed in HBS at a flow rate of 20 or 30 µl/min. Surface regeneration was obtained using injection of HBS supplemented with 0.03% SDS. GST fusion proteins were dialyzed against HBS prior to their use. To avoid aggregates, GST fusion proteins used in SPR experiments were purified by gel filtration on a Superdex S-200 column and used within 48 h. Data were interpreted using BIAevaluation 3.0 software (BIAcore).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

p0071, an Armadillo Repeat Protein, Is a New Partner for Erbin-- To identify new ligands for Erbin, we did a two-hybrid screen of a human breast cDNA library using full-length Erbin as a bait. Two overlapping clones of 543 and 126 aa, respectively, strongly interacted with Erbin but not with control Lamin (data not shown) and are identical to the carboxyl-terminal region of p0071. p0071 is a member of the armadillo family and contains 10 armadillo repeats (38). The p0071 clones bound to constructs encompassing the Erbin PDZ domain (i.e. Erbin, Erbin-(853-1371), and Erbin PDZ domain). Truncation of this region (Erbin.Delta PDZ) abrogated the interaction (Fig. 1A).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1.   p0071 is a new ligand for the Erbin PDZ domain. A, schematic representation of Erbin constructs fused to LexA-BD used in this study. Full-length human Erbin fused to LexA-BD was used to screen a human breast cDNA library by two-hybrid analysis in yeast. Two overlapping positive clones encompassing the p0071 sequence were rechallenged with LexA-BD Erbin or truncated Erbin or Lamin (negative control). Only baits containing the Erbin PDZ domain were reactive in beta -galactosidase activity and grew on -His plates with the clones pulled out of the library. Lamin did not interact with p0071 (not shown). B, Myc-tagged Erbin (Erbin) or Myc-tagged Erbin.Delta PDZ (Erbin.Delta PDZ) was transiently expressed in COS cells and pulled down with GST or GST-p0071 fusion proteins. After Western blot, proteins were detected with anti-Myc antibody. P0071 bound to Erbin but not to Erbin.Delta PDZ. C, Myc-p0071HL was transiently expressed in COS cells and pulled down with the mentioned GST-PDZ domain fusion proteins. After washing, bound proteins were probed with anti-Myc antibody. One-tenth of the lysate used for the precipitation was run as control (total lysate). Comparable amounts of GST fusion proteins were present in the lanes (data not shown).

In the next experiments, we used biochemical assays to confirm the p0071-Erbin interaction. We expressed a Myc-tagged version of Erbin and Erbin.Delta PDZ and performed a pull-down assay with GST-p0071. This fusion protein encompassed the 126 last residues of p0071 fused to the GST protein. Erbin, but not Erbin.Delta PDZ, was precipitated by GST-p0071, confirming that the PDZ domain was sufficient for this interaction (Fig. 1B). We also expressed a Myc-tagged version of p0071 in COS cells and performed a GST pull-down assay with recombinant proteins produced in Escherichia coli. GST-Erbin PDZ domain precipitated p0071, whereas no interaction was found with GST alone (data not shown) and GST fused to Densin-180, AF6, and LIN-2 PDZ domains (Fig. 1C).

The largest clone pulled out of the library encoded the seven last armadillo repeats and the carboxyl terminus of p0071, while the shortest one only encoded the last 126 residues of the protein. The peptide sequence of this latter form, shown in Fig. 2A, contains a carboxyl-terminal SWV motif matching with a class I PDZ domain binding site ((S/T)XV) (39). We precipitated proteins extracted from a Caco-2 cell lysate by GST-p0071 encompassing the last 126 amino acids of p0071. Erbin was efficiently precipitated by a GST-p0071, but not by GST alone (Fig. 2B). The original paper describing the cloning of p0071 mentioned that the SWV motif of p0071 was not located at the very carboxyl-terminal end of the protein (38). However, the p0071 sequence stops with a SWV motif in the two clones pulled out of our two-hybrid screening. Furthermore, we found in databases numerous expressed sequence tags coding for the p0071 carboxyl-terminal sequence that end with the SWV motif. None encoded the longer splice variant described originally. We now know that this discrepancy is due to a sequencing error in the original report describing p0071 cDNA.3


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   The Erbin PDZ domain interacts with the p0071 carboxyl terminus. A, peptide sequence of the shortest p0071 clone. The 15 last residues are underlined. A canonical PDZ domain binding site (SWV) is present in this peptide. B, a pull-down assay was done on a Caco-2 cell lysate with GST or GST-p0071 (126-aa) fusion proteins. After Western blot, proteins were detected with anti-Erbin antibody. Erbin is indicated with an asterisk. One-tenth of the Caco-2 lysate was run as control (TL). C, the 15 carboxyl-terminal amino acids of ERBB2, ERBB4, MUSK, platelet-derived growth factor receptor alpha , Nectin-3, and p0071 were fused to the LexA-BD (baits) and co-transformed in L40 yeast with GAL4 activation domain Erbin PDZ domain (Erbin) or AF6 PDZ domain (AF6) (preys). Co-transformed yeast selected on -Trp-Leu medium were tested for a positive beta -galactosidase activity (beta gal) (left panel). The blue color revealed an interaction between a bait and a prey. Co-transformed yeasts were also plated on -Trp-Leu-His medium containing 10 mM 3-aminotriazole (-His). +, growth on the selective medium (-His + 10 mM 3-aminotriazole) (right panel). D, the last 15 carboxyl-terminal amino acids of p0071 (wild type or mutants) or plakophilins 1-3 were fused to the LexA-BD and co-transformed in L40 yeast with GAL4 activation domain Erbin PDZ domain. Co-transformed yeasts were plated on -Trp-Leu-His medium containing 10 mM 3-aminotriazole. +, growth on the selective medium and positive beta -galactosidase activity. Mutated residues (residues replaced by alanine) are in red. p0071.Delta 4 is truncated of the last 4 residues. E, Erbin was coexpressed with mock vector (vector), Myc-p0071HL (p0071), Myc-p0071Arm (p0071Arm), or Myc-p0071CT (p0071CT) in COS cells. Proteins were immunoprecipitated (IP) with anti-Myc antibody, and bound proteins were detected with anti-Erbin antibody (lower panel). Erbin bound to p0071HL and p0071CT proteins. Lysates were probed with anti-Erbin (upper panel) and anti-Myc (middle panel) antibodies.

The presence of a canonical PDZ binding site in p0071 suggested that this sequence (SWV) is involved in the interaction with the Erbin PDZ domain. To confirm this hypothesis, we fused the p0071 wild-type carboxyl-terminal peptide sequence or mutant forms to LexA-BD. This time, the Erbin PDZ domain was used as a prey and fused to the GAL4 activation domain. The 15 last residues of p0071 or ERBB2 were sufficient to bind to the Erbin PDZ domain (Fig. 2C). Control peptides (ERBB4, MUSK, platelet-derived growth factor receptor, Nectin-3) did not interact with Erbin. The AF6 PDZ domain bound to Nectin-3 (40). Deletion of the DSWV motif (p0071.Delta 4) completely abrogated the interaction (Fig. 2D). We also mutated this motif and found that the carboxyl-terminal valine (position 0) and the tryptophan residue (position -1) are crucial for binding, whereas residues in positions -2 (Ser) and -3 (Asp) support a substitution with an alanine. We have shown that the Erbin PDZ domain prefers a (E/D)(S/T/V)XV peptide binding site (30). The DSWV peptide in p0071 fits with this motif, although the Asp-3 and Ser-2 amino acids did not appear essential for the interaction in the two-hybrid assay (Fig. 2D). p0071 belongs to a subclass of armadillo repeat proteins also comprising plakophilins and p120 catenin-related proteins (33, 38). The plakophilin 1, 2, and 3 carboxyl termini do not contain a DSWV motif and accordingly did not interact with the Erbin PDZ domain by two-hybrid analysis (Fig. 2D). Altogether, these data demonstrate that the Erbin PDZ domain interacts with the p0071 carboxyl terminus.

We also co-expressed in COS cells full-length Erbin with Myc-p0071 headless (p0071HL), Myc-p0071 armadillo repeats (p0071Arm), or Myc-p0071 carboxyl terminus (p0071CT). After cell lysis and immunoprecipitation of proteins with anti-Myc antibody, proteins were resolved by SDS-PAGE and transferred to a membrane. Probing the membrane with anti-Erbin antibody showed that p0071HL and p0071CT, but not p0071Arm, coimmunoprecipitated with Erbin (Fig. 2E). We thus confirmed by precipitation assays with purified fusion proteins, two-hybrid analysis in yeast, and coimmunoprecipitation experiments in COS cells that Erbin and p0071 associate through a PDZ domain interaction.

Use of Surface Plasmon Resonance Analysis to Measure the Erbin-p0071 Interaction-- To gain insight into the respective affinities between Erbin and its ligands (i.e. ERBB2 and p0071), we used surface plasmon resonance analysis. Biotinylated peptides and recombinant GST fusion proteins fused to PDZ domains were tested in the in vitro binding assays. As expected, we found that GST alone (data not shown) or GST-GRB2 did not interact with ERBB2, ERBB4 (not shown), and p0071 peptides (Fig. 3). ERBB2 interacted with the Erbin PDZ domain with a low affinity (KD = 1400 nM). Interestingly, we measured an affinity of 1200 nM between LET-23 and LIN-7 in a similar SPR analysis (data not shown). The affinity between ERBB2 and Erbin is rather low, although both proteins coimmunoprecipitate in cell and tissue extracts (29, 31). Our previous reports demonstrated that the Erbin-ERBB2 interaction is disrupted by the tyrosine phosphorylation of the receptor (29, 30). We believe that a weak interaction between ERBB2 and the Erbin PDZ domain (and perhaps between LET-23 and LIN-7) allows a more dynamic regulation of this interaction to occur in vivo. We measured a better affinity between p0071 and Erbin (KD = 88 nM). This affinity is within the same range as those observed for other PDZ domain-peptide interactions (39).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   SPR analysis of binding of Erbin to p0071 and ERBB2. A, direct association of Erbin with p0071 and ERBB2. 1 µM GST-Erbin was injected at a flow rate of 20 µl/min on either ERBB2-coated surface (300 RU) or p0071-coated surface (57 RU). As a control, the irrelevant GST-GRB2 was injected in a same way. Binding of GRB2 to ERBB2 or p0071 peptides was not significant. B, determination of equilibrium dissociation constants KD. Injections of GST-fusion proteins were performed at a flow rate of 30 µl/min until equilibrium state was reached. The Erbin fusion protein was injected on ERBB2-coated surface (59 RU) and p0071-coated surface (57 RU) at concentrations ranging from 50 to 250 nM and 500 nM to 8 µM, respectively. Responses at the equilibrium (Req) were plotted against (Req/c) each GST fusion protein concentration. Equilibrium dissociation constant KD value was calculated from the slope of this linear regression, Req = -KD·Req/c + Rmax. One representative experiment of two is shown. C, comparison of the equilibrium dissociation constants (KD).

Erbin and p0071 Proteins Interact in Vivo-- We next examined the in vivo interaction between Erbin and p0071 by coimmunoprecipitation with endogenous proteins. We produced mouse monoclonal anti-Erbin antibodies using a GST-Erbin-(1241-1370) as immunogen (see "Materials and Methods"). Monoclonal R24 and R99 mAb immunoprecipitated Erbin from a Caco-2 cell lysate (Fig. 4A). Caco-2 cell extracts were used to examine the in vivo interaction between Erbin and p0071. When we used an anti-p0071 monoclonal antibody to reveal proteins bound to immunoprecipitated Erbin, a 130-kDa protein corresponding to p0071 was detected (Fig. 4B). A similar result was obtained when we used a mouse brain extract as a source of Erbin and p0071 (Fig. 4C). We thus showed that Erbin and p0071 interact in epithelial cells and in mouse brain. Taken together, we have established that Erbin binds to p0071 in vitro and in vivo.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 4.   Erbin and p0071 interact in vivo. A, Balb/c mice were injected with a soluble GST-Erbin PDZ domain, and immune serum (IS) precipitated Erbin from a Caco-2 cell lysate (right lane). No immunoprecipitation was obtained with a BALB/C mice preimmune serum (P). Spleen cells of immunized mice were fused to the nonsecreting myeloma X63-Ag8.653, and clones were screened for anti-Erbin reactivity. Supernatants from R24 and R99 clones immunoprecipitated Erbin, whereas the culture medium (med) or a control monoclonal antibody (alpha myc) did not. One-tenth of the Caco-2 lysate used for immunoprecipitation was run as control (TL). B, a Caco-2 cell extract was incubated with R24 or R99 clones or anti-Myc (alpha myc) antibody, and bound proteins were separated on SDS-PAGE and transferred on nitrocellulose. The membrane was revealed with mouse monoclonal anti-p0071 (upper panel) or rabbit polyclonal anti-Erbin antibodies (lower panel). Co-immunoprecipitation between p0071 and Erbin was observed with anti-Erbin antibody but not the control antibody. C, same as B with mouse brain extract.

Erbin and p0071 Proteins Colocalize in Epithelial Cells and in Tissues-- LAP proteins are membrane-associated proteins targeted to the basolateral membrane of polarized epithelial cells (20, 21, 28, 29). We first expressed Myc-p0071 in MCF-7 cells, where Erbin is endogenously present, and performed double immunostaining experiments with anti-Erbin and anti-Myc antibodies. Erbin and p0071 colocalized at cell-cell contacts in Myc-p0071-positive cells (Fig. 5A). In polarized Caco-2 cells, where endogenous p0071 and Erbin can be detected, Erbin partially colocalized with p0071 (Fig. 5B). p0071 was localized both intracellularly and to specific areas on the lateral membrane, probably enriched in desmosomes (38). In these areas, a colocalization with Erbin was detected (Fig. 5B). To evaluate the colocalization in the desmosomes, we performed double immunolabeling and an immunoelectron microscopy analysis with secondary antibodies coupled to gold particles of different sizes (Fig. 6). Clearly, Erbin was present in desmosomes where it was in close vicinity with p0071, indicating that the two proteins interact in these structures.


View larger version (87K):
[in this window]
[in a new window]
 
Fig. 5.   Partial co-localization of Erbin and p0071 in epithelial cells. A and B, confocal XY sections of MCF-7 (A) and Caco-2 (B) cells double-labeled for Erbin and p0071 (recognized by anti-Myc antibody in A and by anti-p0071 antibody in B). In B, the right panel shows the merge of the two confocal sections (Erbin in red and p0071 in green). Erbin and p0071 colocalize at the lateral membrane (arrowheads). Scale bar, 10 µm.


View larger version (122K):
[in this window]
[in a new window]
 
Fig. 6.   Erbin and p0071 colocalize in desmosomes. Double immunostaining for Erbin (6-nm gold particles) and p0071 (15-nm gold particles) in ultrathin cryosections of human colonic epithelium (left and middle panels). Erbin labeling (arrows) is observed at the lateral plasma membrane (pm) and over the desmosomes (D) containing p0071 (arrowheads). A detailed view of a desmosome (D) stained for Erbin shows a cluster of 6-nm gold particles (arrow) in the desmosomal plaque (right panel). Bar, 0.1 µm.

Dominant Negative p0071 Affects Epithelial Integrity in HeLa Cells-- To gain insight on the functional relevance of the Erbin-p0071 interaction, we constructed a potentially dominant-negative mutant of p0071 susceptible to disrupt the interaction with Erbin. We expressed GFP-p0071CT and GFP-p0071CT.Delta 4 (a protein lacking the PDZ domain binding site) and GFP-PICK1 (a control protein) in HEK 293 cells and showed that these proteins are equally expressed (Fig. 7A). We then expressed the GFP fusion proteins in HeLa cells, and we performed immunostaining with anti-Erbin antibody to stain the epithelial membranes. GFP-p0071CT induced a profound effect on the morphology of cells with disruption of cell-cell contacts (Fig. 7, B and C). This effect was specific, since GFP-PICK1 and GFP-p0071CT.Delta 4, which are unable to bind to Erbin, failed to produce this phenotype (Fig. 7C). We evaluated the percentage of cells giving an altered phenotype with the different GFP constructs by counting the cells in three different experiments. For GFP-PICK1 and GFP-p0071CT.Delta 4, we obtained 7.5 ± 3.5 and 16.5 ± 6.4%, respectively, of altered morphologies, whereas GFP-p0071CT gave 61 ± 19.8% of altered cells. Furthermore, many patches of living green cells expressing GFP-p0071CT.Delta 4 were obtained, whereas GFP-p0071CT-expressing cells were rare and presented aberrant morphologies. We conclude that p0071 interacts with Erbin through its carboxyl terminus and forms protein complexes important for epithelial integrity.


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 7.   Dominant-negative p0071 disrupts epithelial integrity. A, extracts of HEK 293 cells transiently expressing GFP-PICK1 (lane 1), GFP-p0071CT (lane 2), and GFP-p0071CT.Delta 4 (lane 3) were separated by SDS-PAGE, and proteins were revealed with an anti-GFP antibody. B, GFP-p0071CT-expressing HeLa cells (left panel, arrowhead) show an altered morphology compared with untransfected cells (right panel, phase contrast). C, confocal XY sections of HeLa cells transiently transfected with the mentioned GFP constructs and labeled for endogenous Erbin (red). The upper panel shows the merge of the two confocal sections (Erbin in red and GFPs in green). The lower panel only shows immunostainings of Erbin. GFP-p0071CT (middle), but not GFP-p0071CT.Delta 4 (left) or GFP-PICK1 (right), altered the integrity of the cell monolayer (arrowheads).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Identification of protein networks associated with LAP proteins will help to decipher their functions in combination with genetic studies in animals. LET-413 and Scribble are basolateral and septate junction-associated proteins involved in the localization of apical proteins and epithelial integrity, although molecular mechanisms underlying these functions remain unknown (20, 21). In nonvertebrates, loss of function of let-413 and scribble genes provokes cytoskeletal defects and lethality. It is likely that LET-413 and Scribble, as well as their mammalian homologues may be connected, directly or not, to cytoskeleton-associated proteins. Likewise, Erbin was recently shown to interact with BPAG1, a plakin associated with intermediate filaments in epithelial cells (32).

Here, we have identified a direct interaction between Erbin and p0071, a cell-cell contact-associated protein. The PDZ domain of Erbin binds specifically and directly to the very carboxyl-terminal residues of p0071 (DSWV motif). We demonstrated the in vivo interaction between Erbin and p0071 in pull-down and co-immunoprecipitation experiments. We measured a better affinity between Erbin and p0071 than between Erbin and ERBB2 by SPR analysis using 15-mer biotinylated peptides. In epithelial cells, different pools of Erbin may thus bind to p0071 and ERBB2 to participate in multiple biological functions including receptor localization or cell signaling (29, 35).

Catenin-related proteins such as p0071 are armadillo repeat proteins presumably bound to actin or intermediate filaments and link adherens junctions and/or desmosomes to the cytoskeleton (34, 41). We found that Erbin indeed colocalized with p0071 in desmosomes of human colon cells and was also found all along the lateral membrane of epithelial cells. Desmocollins and desmogleins, members of the cadherin superfamily, are the major desmosomal glycoproteins. We did not detect an interaction between Erbin and Desmoglein-1 in Caco-2 cells by coimmunoprecipitation (not shown), but a more exhaustive study is needed to address the question of whether Erbin interacts with one of these cell adhesion molecules. Nevertheless, p0071 is not restricted to these compartments in epithelial cells (38).

Adherens junctions but not desmosomes are present in worms and flies, and a plakophilin/catenin-like protein 38% identical to p0071 is found in C. elegans data bases (accession number CAB60320). Interestingly, a DSWV motif terminates its peptide sequence, suggesting that interactions between armadillo repeat proteins and PDZ domains are conserved throughout evolution. We obtained no obvious phenotype using an RNA interference strategy in C. elegans to abolish the CAB60320 expression.4 p0071, also called plakophilin-4, is distantly related to the three bona fide plakophilins and is more related to catenins of the p120 catenin family. Plakophilins and p120 catenin have important functions in signaling, adhesion processes, and tissue integrity (35). p120 catenin is a substrate of the SRC tyrosine kinase and participates in the regulation of cell adhesion (34). In humans, plakophilin 1 deficiency provokes a skin fragility syndrome by failure to properly assemble desmosomes (42). Regarding the defects of adherens junction integrity in let-413 and scribble mutants (20, 21), it is tempting to hypothesize that LAP proteins and armadillo repeat proteins act altogether to create or maintain cell-cell junctions (adherens junctions, desmosomes) and contribute to the integrity of epithelial tissues. Disruption of the p0071-Erbin interaction by expressing a dominant negative p0071 (GFP-p0071CT) may destabilize these structures, leading to abnormal cellular morphologies (Fig. 7). Erbin is probably only one component of protein complexes involved in these processes, since other PDZ proteins, including Papin, bind to p0071. Papin, a novel PDZ domain protein, interacts with p0071 in the insoluble fraction of cell extracts, whereas we recover the p0071-Erbin interaction in a 1% Triton X-100 extraction buffer (43). Other studies have shown that protein complexes containing p0071 or delta -catenin/NPRAP, a p0071-like protein, are extractable by a Triton-based buffer (44, 45). Different pools of p0071 may thus be present in distinct subcellular compartments. LAP proteins also function in nonepithelial tissues (29, 31). Interestingly, in neurons, the p0071 armadillo repeat domain binds to the hydrophilic loop of presenilin 1 (PSEN1), a protein involved in neurodegenerative disorders (45). Since Erbin is expressed in the brain, a tripartite PSEN1-p0071-Erbin complex may be involved in neuronal functions still to be identified.

The presence of Erbin in desmosomes (this study) and in hemidesmosomes, as suggested by others (32), leads us to propose that Erbin plays a role in the establishment and the maintenance of cell-cell and cell-basement membrane adhesion. Disruption of these structures required for stable epithelial cell anchorage and polarity is frequently observed in cancers. Although the role of Erbin and other LAP proteins has to be evaluated in pathology, the multiple protein interactions found with well known or putative oncoproteins (E6, ERBB2) or tumor suppressors (hDLG, p0071) suggest their involvement in cancers (27-29). A relationship between LAP proteins and tumorigenic processes exists in Drosophila, since scribble behaves as a tumor suppressor gene (22). Furthermore, due to its participation in desmosomal and hemidesmosomal protein networks, Erbin may also be implicated in skin diseases such as bullous pemphigoid and junctional epidermolysis bullosis (33, 46). Identification of protein networks associated to LAP proteins should help to understand their roles in cellular and developmental processes as well as in human diseases.

    ACKNOWLEDGEMENTS

We are grateful to Dr. Monges for human colon samples; Daniel Isnardon and Remi Galindo for imaging and cell sorting expertise; and Dr. Claude Mawas, Ben Margolis, and Dr. Michel Labouesse for comments and support.

    FOOTNOTES

* This project is supported by INSERM, ARC, La Ligue Nationale Contre le Cancer (Label Ligue), Fondation de France (to J.-P. B.) and Institute Paoli-Calmettes (to D. B. and J.-P. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

b Recipient of a Ministry of Research and Technology fellowship.

e Recipient of a Conseil Régional fellowship.

g Recipient of a Japanese-French fellowship.

i Supported by Deutsche Forschungsgemeinschaft grants Ha1791/3-3 and Ha1791/5-2 and the BMBF (Molecular Biology Group of Medical Faculty).

j To whom correspondence should be addressed: U119 INSERM, Molecular Oncology, 27 Blvd. Leï Roure 13009 Marseille, France. Tel.: 33-4-91-75-84-09; Fax: 33-4-91-26-03-64; E-mail: borg@marseille.inserm.fr.

Published, JBC Papers in Press, November 15, 2001, DOI 10.1074/jbc.M109652200

2 M. Hatzfeld, manuscript in preparation.

3 M. Hatzfeld, personal communication.

4 M. Labouesse, personal communication.

    ABBREVIATIONS

The abbreviations used are: SPR, surface plasmon resonance; PBS, phosphate-buffered saline; HEK, human embryonic kidney; GST, glutathione S-transferase; aa, amino acids; GFP, green fluorescent protein; RU, resonance unit.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Drubin, D. G., and Nelson, W. J. (1996) Cell 84, 335-344
2. Caplan, M. J. (1997) Am. J. Physiol. 272, F425-F429
3. Yeaman, C., Grindstaff, K. K., Hansen, M. D., and Nelson, W. J. (1999) Curr. Biol. 9, R515-R517
4. Pawson, T., and Scott, J. D. (1997) Science 278, 2075-2080
5. Fanning, A. S., and Anderson, J. M. (1998) Curr. Top. Microbiol. Immunol. 228, 209-233
6. Migaud, M., Charlesworth, P., Dempster, M., Webster, L. C., Watabe, A. M., Makhinson, M., He, Y., Ramsay, M. F., Morris, R. G., Morrison, J. H., O'Dell, T. J., and Grant, S. G. (1998) Nature 396, 433-439
7. Hildebrand, J. D., and Soriano, P. (1999) Cell 99, 485-497
8. Borg, J.-P., Straight, S. W., Kaech, S. M., de Taddéo-Borg, M., Kroon, D. E., Karnak, D., Turner, R. S., Kim, S. K., and Margolis, B. (1998) J. Biol. Chem. 273, 31633-31636
9. Kaech, S. M., Whitfield, C. W., and Kim, S. K. (1998) Cell 94, 761-771
10. Hung, T. J., and Kemphues, K. J. (1999) Development 126, 127-135
11. Joberty, G., Petersen, C., Gao, L., and Macara, I. G. (2000) Nat Cell Biol. 2, 531-539
12. Lin, D., Edwards, A. S., Fawcett, J. P., Mbamalu, G., Scott, J. D., and Pawson, T. (2000) Nat Cell Biol. 2, 540-547
13. Chevesich, J., Kreuz, A. J., and Montell, C. (1997) Neuron 18, 95-105
14. Tsunoda, S., Sierralta, J., Sun, Y., Bodner, R., Suzuki, E., Becker, A., Socolich, M., and Zuker, C. S. (1997) Nature 388, 243-249
15. Kim, E., Niethammer, M., Rothschild, A., Jan, Y. N., and Sheng, M. (1995) Nature 378, 85-88
16. Kornau, H.-C., Schenker, L. T., Kennedy, M. B., and Seeburg, P. H. (1995) Science 269, 1737-1740
17. Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, Y., Rosahl, T. W., and Sudhof, T. C. (1997) Science 277, 1511-1515
18. Huang, Y. Z., Won, S., Ali, D. W., Wang, Q., Tanowitz, M., Du, Q. S., Pelkey, K. A., Yang, D. J., Xiong, W. C., Salter, M. W., and Mei, L. (2000) Neuron 26, 443-455
19. Bilder, D., Birnbaum, D., Borg, J.-P., Bryant, P., Huigbretse, J., Jansen, E., Kennedy, M. B., Labouesse, M., Legouis, R., Mechler, B., Perrimon, N., Petit, N., and Sinha, P. (2000) Nat. Cell Biol. 7, E114
20. Bilder, D., and Perrimon, N. (2000) Nature 403, 676-680
21. Legouis, R., Gansmuller, A., Sookhareea, S., Bosher, J. M., Baillie, D. L., and Labouesse, M. (2000) Nat. Cell Biol. 2, 415-422
22. Bilder, D., Li, M., and Perrimon, N. (2000) Science 289, 113-116
23. McMahon, L., Legouis, R., Vonesch, J. L., and Labouesse, M. (2001) J. Cell Sci. 114, 2265-2277
24. Bossinger, O., Klebes, A., Segbert, C., Theres, C., and Knust, E. (2001) Dev. Biol. 230, 29-42
25. Apperson, M. L., Moon, I. S., and Kennedy, M. B. (1996) J. Neurosci. 16, 6839-6852
26. Walikonis, R. S., Oguni, A., Khorosheva, E. M., Jeng, C.-J., Asuncion, F. J., and Kennedy, M. B. (2001) J. Neurosci. 21, 423-433
27. Nakagawa, S., and Huibregtse, J. M. (2000) Mol. Cell. Biol. 20, 8244-8253
28. Saito, H., Santoni, M. J., Arsanto, J.-P., Jaulin-Bastard, F., Le, Bivic, A., Marchetto, S., Audebert, S., Isnardon, D., Adelaide, J., Birnbaum, D., and Borg, J.-P. (2001) J. Biol. Chem. 276, 32051-32055
29. Borg, J.-P., Marchetto, S., Le, Bivic, A., Ollendorff, V., Jaulin-Bastard, F., Saito, H., Fournier, E., Adélaïde, J., Margolis, B., and Birnbaum, D. (2000) Nat. Cell Biol. 7, 407-414
30. Jaulin-Bastard, F., Saito, H., Le, Bivic, A., Ollendorff, V., Marchetto, S., Birnbaum, D., and Borg, J.-P. (2001) J. Biol. Chem. 276, 15256-15263
31. Huang, Y. Z., Wang, Q., Xiong, W. C., and Mei, L. (2001) J. Biol. Chem. 276, 19318-19326
32. Favre, B., Fontao, L., Koster, J., Shafaatian, R., Jaunin, F., Saurat, J. H., Sonnenberg, A., and Borradori, L. (2001) J. Biol. Chem. 276, 32427-32436
33. Green, K. J., and Gaudry, C. A. (2000) Nature (Mol. Cell. Biol.) 1, 208-216
34. Anastasiadis, P. Z., and Reynolds, A. B. (2000) J. Cell Sci. 113, 1319-1334
35. Hatzfeld, M. (1999) Int. Rev. Cytol. 186, 179-224
36. Borg, J.-P., Ooi, J. Y., Levy, E., and Margolis, B. (1996) Mol. Cell. Biol. 16, 6229-6241
37. Rosnet, O., Buhring, H. J., Marchetto, S., Rappold, I., Lavagna, C., Sainty, D., Arnoulet, C., Chabannon, C., Kanz, L., Hannum, C., and Birnbaum, D. (1996) Leukemia 10, 238-248
38. Hatzfeld, M., and Nachtsheim, C. (1996) J. Cell Sci. 109, 2767-2778
39. Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., and Cantley, L. C. (1997) Science 275, 73-77
40. Reymond, N., Borg, J.-P., Lecocq, E., Adelaide, J., Campadelli-Fiume, G., Dubreuil, P., and Lopez, M. (2000) Gene (Amst.) 255, 347-355
41. Hatzfeld, M., Haffner, C., Schulze, K., and Vinzens, U. (2000) J. Cell Biol. 149, 209-222
42. McGrath, J. A., McMillan, J. R., Shemanko, C. S., Runswick, S. K., Leigh, I. M., Lane, E. B., Garrod, D. R., and Eady, R. A. (1997) Nat. Genet. 17, 240-244
43. Deguchi, M., Iizuka, T., Hata, Y., Nishimura, W., Hirao, K., Yao, I., Kawabe, H., and Takai, Y. (2000) J. Biol. Chem. 275, 29875-29880
44. Lu, Q., Paredes, M., Medina, M., Zhou, J., Cavallo, R., Peifer, M., Orecchio, L., and Kosik, K. S. (1999) J. Cell Biol. 144, 519-532
45. Stahl, B., Diehlmann, A., and Sudhof, T. C. (1999) J. Biol. Chem. 274, 9141-9148
46. Jones, J. C. R., Hopkinson, S. B., and Goldfinger, L. E. (1998) Bioessays 20, 488-494


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GENES CELLSHome page
I. Izawa, M. Nishizawa, Y. Hayashi, and M. Inagaki
Palmitoylation of ERBIN is required for its plasma membrane localization.
Genes Cells, July 1, 2008; 13(7): 691 - 701.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. D. Mruk, B. Silvestrini, and C. Y. Cheng
Anchoring Junctions As Drug Targets: Role in Contraceptive Development
Pharmacol. Rev., June 1, 2008; 60(2): 146 - 180.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
N. Liu, J. Zhang, J. Zhang, S. Liu, Y. Liu, and D. Zheng
Erbin-regulated Sensitivity of MCF-7 Breast Cancer Cells to TRAIL via ErbB2/AKT/NF-{kappa}B Pathway
J. Biochem., June 1, 2008; 143(6): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Dai, C. Chang, X. Lin, P. Dai, L. Mei, and X.-H. Feng
Erbin Inhibits Transforming Growth Factor {beta} Signaling through a Novel Smad-Interacting Domain
Mol. Cell. Biol., September 1, 2007; 27(17): 6183 - 6194.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. B. Silverman, S. Restituito, W. Lu, L. Lee-Edwards, L. Khatri, and E. B. Ziff
Synaptic Anchorage of AMPA Receptors by Cadherins through Neural Plakophilin-Related Arm Protein AMPA Receptor-Binding Protein Complexes
J. Neurosci., August 8, 2007; 27(32): 8505 - 8516.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. A. Stiffler, J. R. Chen, V. P. Grantcharova, Y. Lei, D. Fuchs, J. E. Allen, L. A. Zaslavskaia, and G. MacBeath
PDZ Domain Binding Selectivity Is Optimized Across the Mouse Proteome
Science, July 20, 2007; 317(5836): 364 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Appleton, Y. Zhang, P. Wu, J. P. Yin, W. Hunziker, N. J. Skelton, S. S. Sidhu, and C. Wiesmann
Comparative Structural Analysis of the Erbin PDZ Domain and the First PDZ Domain of ZO-1: INSIGHTS INTO DETERMINANTS OF PDZ DOMAIN SPECIFICITY
J. Biol. Chem., August 4, 2006; 281(31): 22312 - 22320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, S. Yeh, B. A. Appleton, H. A. Held, P. J. Kausalya, D. C. Y. Phua, W. Lee Wong, L. A. Lasky, C. Wiesmann, W. Hunziker, et al.
Convergent and Divergent Ligand Specificity among PDZ Domains of the LAP and Zonula Occludens (ZO) Families
J. Biol. Chem., August 4, 2006; 281(31): 22299 - 22311.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Takizawa, K. Nagasaka, S. Nakagawa, T. Yano, K. Nakagawa, T. Yasugi, T. Takeuchi, T. Kanda, J. M. Huibregtse, T. Akiyama, et al.
Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli
Genes Cells, April 1, 2006; 11(4): 453 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Dai, W. C. Xiong, and L. Mei
Erbin Inhibits RAF Activation by Disrupting the Sur-8-Ras-Raf Complex
J. Biol. Chem., January 13, 2006; 281(2): 927 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. McDonald, F. F. Chen, V. Ollendorff, Y. Ogura, S. Marchetto, P. Lecine, J.-P. Borg, and G. Nunez
A Role for Erbin in the Regulation of Nod2-dependent NF-{kappa}B Signaling
J. Biol. Chem., December 2, 2005; 280(48): 40301 - 40309.
[Abstract] [Full Text] [PDF]